全文获取类型
收费全文 | 1575篇 |
免费 | 160篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 60篇 |
妇产科学 | 37篇 |
基础医学 | 198篇 |
口腔科学 | 5篇 |
临床医学 | 161篇 |
内科学 | 315篇 |
皮肤病学 | 13篇 |
神经病学 | 55篇 |
特种医学 | 13篇 |
外科学 | 382篇 |
综合类 | 69篇 |
预防医学 | 138篇 |
眼科学 | 8篇 |
药学 | 139篇 |
中国医学 | 7篇 |
肿瘤学 | 123篇 |
出版年
2023年 | 17篇 |
2022年 | 6篇 |
2021年 | 38篇 |
2020年 | 48篇 |
2019年 | 43篇 |
2018年 | 31篇 |
2017年 | 46篇 |
2016年 | 37篇 |
2015年 | 68篇 |
2014年 | 60篇 |
2013年 | 73篇 |
2012年 | 103篇 |
2011年 | 118篇 |
2010年 | 73篇 |
2009年 | 63篇 |
2008年 | 102篇 |
2007年 | 93篇 |
2006年 | 83篇 |
2005年 | 92篇 |
2004年 | 48篇 |
2003年 | 48篇 |
2002年 | 41篇 |
2001年 | 45篇 |
2000年 | 35篇 |
1999年 | 37篇 |
1998年 | 11篇 |
1997年 | 19篇 |
1996年 | 9篇 |
1995年 | 9篇 |
1994年 | 9篇 |
1993年 | 6篇 |
1992年 | 21篇 |
1991年 | 11篇 |
1990年 | 16篇 |
1989年 | 17篇 |
1988年 | 11篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 7篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1974年 | 9篇 |
1972年 | 11篇 |
1971年 | 7篇 |
1970年 | 6篇 |
1969年 | 6篇 |
排序方式: 共有1737条查询结果,搜索用时 15 毫秒
21.
Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with vasodilators and other antihypertensive drugs, anticoagulants and antiplatelet drugs, thrombolytic agents, and lipid-lowering agents. 相似文献
22.
Makkuni D Bharadwaj A Wolfe K Payne S Hutchings A Dasgupta B 《Rheumatology (Oxford, England)》2008,47(4):488-490
Objective. The ischaemic complications of giant cell arteritis(GCA) such as blindness and stroke may result from luminal narrowingof the affected arteries. This study focuses on the associationbetween the severity of intimal proliferation on temporal arterybiopsy (TAB) histology and neuro-ophthalmic complications (NOCs)of GCA. Method. We identified 30 cases of biopsy-proven temporal arteritis.One histopathologist (blinded to the clinical details) evaluatedthe TAB specimens and categorized the degree of maximum stenosisdue to intimal hyperplasia into four grades: grade 1 is <50%luminal occlusion due to intimal hyperplasia, grade 2 is 50–75%,grade 3 is >75% and grade 4 is complete luminal occlusion.A second histopathologist (also blinded to the clinical details)independently evaluated the TAB specimens using the same gradingsystem. The NOCs in these patients were noted after a case recordreview. Results. Of the 30 patients, 12 had NOC-10 with eye complications(complete visual loss, anterior ischaemic neuropathy, visualfield defects), one patient had cerebral infarcts and one hadboth cerebral infarcts and vision loss. There was evidence fora statistically significant trend of NOC associated with higherintimal hyperplasia scores (P = 0.001). The scores of the histopathologistsagreed for 23 (77%) patients and differed by 1 category forthe remaining 7 (-statistic 0.88). Conclusions. Our study suggests that the degree of intimal hyperplasiaon TAB histology (routinely available to all hospital units)seems to be closely associated with NOCs of GCA. The study highlightsthe possible prognostic as well as diagnostic role of the biopsy.We feel that intimal hyperplasia noted in biopsy specimens mayhelp us in the risk stratification of GCA patients and targetingof appropriate and novel therapies. KEY WORDS: Intimal hyperplasia, Giant cell arteritis, Neuro-ophthalmic complications
Submitted 1 June 2007; revised version accepted 7 January 2008. 相似文献
23.
Identification of a mammalian gene structurally and functionally related to the CDC25 gene of Saccharomyces cerevisiae. 下载免费PDF全文
W Wei R D Mosteller P Sanyal E Gonzales D McKinney C Dasgupta P Li B X Liu D Broek 《Proceedings of the National Academy of Sciences of the United States of America》1992,89(15):7100-7104
The yeast Saccharomyces cerevisiae CDC25 gene encodes a nucleotide-exchange-factor (NEF) that can convert the inactive GDP-bound state of RAS proteins to an active RAS-GTP complex. CDC25 can activate the yeast RAS proteins as well as the human H-ras protein. CDC25 is a member of a family of yeast genes that likely encode NEFs capable of regulating the RAS-related proteins found in yeast. By aligning the amino acid sequence of CDC25-related gene products we found a number of conserved motifs. Using degenerate oligonucleotides that encode these conserved sequences, we have used polymerase chain reactions to amplify fragments of mouse and human cDNAs related to the yeast CDC25 gene. We show that a chimeric molecule, part mouse and part yeast CDC25, can suppress the loss of CDC25 function in the yeast S. cerevisiae. 相似文献
24.
Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. 总被引:2,自引:6,他引:2 下载免费PDF全文
B Dasgupta O Duke A M Timms C Pitzalis G S Panayi 《Annals of the rheumatic diseases》1989,48(4):307-311
A prospective study of 33 patients with polymyalgia rheumatica/giant cell arteritis (PMR/GCA) was undertaken, firstly, to monitor sequentially peripheral blood CD8+ lymphocyte levels and, secondly, to assess the expression of activation markers on T lymphocyte subsets. The results indicated that there was a significant decrease in absolute numbers and relative percentages of CD8+ T lymphocytes, which returned to normal ranges after approximately 24 months' treatment, and that there was an increased percentage of CD8+ lymphocytes in PMR/GCA which express HLA class II antigens. 相似文献
25.
26.
27.
28.
29.
Mortality in diabetes compared with previous cardiovascular disease: A gender-specific meta-analysis
AimsDiabetes has been described as a cardiovascular disease (CVD) risk equivalent. There is evidence, however, that its impact may differ between women and men. For this reason, our study aimed to obtain gender-specific hazard ratios (HRs) comparing diabetes and CVD patients in terms of all-cause, CVD and coronary heart disease (CHD) mortality.MethodsIndividuals with diabetes (without CVD) and those with CVD (without diabetes) were examined through a systematic review of articles that provided gender-specific HRs for mortality. Searches included Medline, Embase and the Cochrane Library database (from January 1998 to December 2009) and exploded MeSH headings [cardiovascular diseases, risk, epidemiologic studies, case-control studies, cohort studies, mortality, outcome assessment (health care), sex factors, survival analysis and diabetes mellitus, type 2]. Two observers selected and reviewed the studies and hierarchical Bayesian random-effects models were used to combine HRs, thereby accommodating any between-study differences through inclusion of a between-study variance in HRs.ResultsOut of 5425 studies, nine were relevant (0.17%). CVD and CHD mortality in men was lower for diabetes alone (CVD mortality HR: 0.82, 95% CrI: 0.69–0.98; CHD mortality HR: 0.73, 95% CrI: 0.65–0.83). In contrast, rates appeared to be higher in women with diabetes alone (CVD mortality HR: 1.29, 95% CrI: 0.79–2.26; CHD mortality HR: 1.28, 95% CrI: 0.75–2.22), although wide credible intervals precluded any definitive conclusions. All-cause mortality in men was similar for diabetes and previous CVD (HR: 1.02, 95% CrI: 0.93–1.12) whereas, among women, it was at least as high and possibly higher for diabetes alone (HR: 1.25, 95% CrI: 0.89–1.76).ConclusionCompared with previous CVD, diabetes alone leads to lower CVD and CHD mortality risk in men, and similar all-cause mortality. In contrast, although further studies are needed, it is possible that diabetes leads to higher CVD, CHD and all-cause mortality in women. 相似文献
30.